의료용 플라스틱 튜브 시장 : 소재별, 구조별, 용도별, 지역별 - 세계 예측(-2031년)

The medical plastics tubing market is projected to reach USD 6.81 billion by 2031 from USD 4.83 billion in 2026 at a CAGR of 7.1% during the forecast period.

The market is rapidly growing globally due to increased healthcare needs and the demand for safe, reliable, high-quality fluid and gas transfer solutions.

"Polyethylene (PE) is projected to be the second-largest material in the medical plastics tubing market during the forecast period."

In the medical plastics tubing market, polyethylene (PE) is expected to be the second-largest segment, owing to its high performance, which is due to a good combination of flexibility, chemical resistance, and biocompatibility. PE has good physical-mechanical properties, low water absorption, and is easily processable. As a result, it is used in various pharmaceutical testing applications, such as fluid handling systems, IV tubing, and single-use medical appliances.

"Catheters & cannulas are projected to be the largest application of medical plastics tubing during the forecast period."

Catheters and cannulas are utilized in both routine and critical medical procedures. Medical plastic tubing in these applications provides a safe and reliable method for delivering or removing drugs, fluids, or gases within the human body. Key factors driving the growth of this segment include the rising prevalence of chronic diseases, an increase in the number of surgeries, and a surge in minimally invasive procedures. Additionally, advancements in catheter and cannula design and materials, greater adoption of single-use medical plastic tubing products, and an increasing demand for biocompatible materials are further contributing to this segment's growth.

"North America is projected to be the largest region in the global medical plastics tubing market during the forecast period."

North America is expected to be the largest market for medical plastics tubing during the forecast period. This is mainly because of the region's strong presence of highly developed healthcare infrastructure and the widespread use of innovative medical technologies. Also, the region has a well-established medical device manufacturing industry, rising healthcare spending, and increasing demand for minimally invasive procedures. The increasing number of individuals affected by chronic illnesses, the rise in home healthcare services, and a strong emphasis on patient safety and product quality are key factors driving market growth. Additionally, the presence of leading medical device companies in both the US and Canada, along with ongoing investments in research and development and advanced polymer technologies, have solidified North America's dominance in the global medical plastics tubing market.

Breakdown of Primary Interviews

By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%

By Designation: Directors: 30%, Managers: 20%, and Others: 50%

By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa: 20%

Notes: Others include sales, marketing, and product managers.

Tier 1: >USD 1 Billion; Tier 2: USD 500 million-1 Billion; and Tier 3: <USD 500 million

Companies Covered: Saint-Gobain (France), Nordson Corporation (US), Freudenberg Medical (US), Trelleborg AB (Sweden), Lubrizol (US), W. L. Gore & Associates, Inc. (US), Biomerics (US), RAUMEDIC AG (Germany), Zeus Company LLC (US), and Optinova (Finland), among others, are covered in the report.

The study includes an in-depth competitive analysis of these key players in the medical plastics tubing market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the medical plastics tubing market based on material (PVC, PE, PP, PA, PTFE, PEEK, TPE), structure (single-lumen, multi-lumen, co-extruded, tapered or bump tubing, braided tubing), and application (bulk disposable tubing, catheters & cannulas, drug delivery systems). The report's scope covers detailed information regarding drivers, restraints, challenges, and opportunities influencing the growth of the medical plastics tubing market. A detailed analysis of the key industry players has been done to provide insights into their business overviews, products offered, and key strategies, such as mergers, acquisitions, product launches, and expansions, associated with the medical plastics tubing market. This report covers a competitive analysis of upcoming startups in the medical plastics tubing market ecosystem.

Reasons to Buy the Report

The report will offer the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall medical plastics tubing market and the subsegments. This report will help stakeholders understand the competitive landscape, gain more insights into positioning their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

• Analysis of key drivers (accelerating global aging population and rising chronic disease burden and expanding adoption of minimally invasive surgery and catheter-based procedures), restraints (escalating regulatory compliance burden across jurisdictions and health and environmental concerns over PVC and phthalate plasticizers), opportunities (advancements in biocompatible and smart materials and increasing governmental expenditure for upgrading and developing healthcare infrastructure), and challenges (navigating an increasingly complex and divergent global regulatory environment and R=raw material supply chain fragility and resin price volatility)
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the medical plastics tubing market
• Market Development: Comprehensive information about profitable markets (the report analyzes the medical plastics tubing market across varied regions)
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical plastics tubing market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Saint-Gobain (France), Nordson Corporation (US), Freudenberg Medical (US), Trelleborg AB (Sweden), Lubrizol (US), W. L. Gore & Associates, Inc. (US), Biomerics (US), RAUMEDIC AG (Germany), Zeus Company LLC (US), and Optinova (Finland), among others

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
  • 1.3.4 UNITS CONSIDERED
• 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MEDICAL PLASTICS TUBING MARKET
• 2.4 HIGH GROWTH SEGMENTS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR MEDICAL PLASTICS TUBING MARKET PLAYERS
• 3.2 MEDICAL PLASTICS TUBING MARKET, BY MATERIAL
• 3.3 MEDICAL PLASTICS TUBING MARKET, BY STRUCTURE
• 3.4 MEDICAL PLASTICS TUBING MARKET, BY APPLICATION
• 3.5 MEDICAL PLASTICS TUBING MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Accelerating Global Aging Population and Rising Chronic Disease Burden
    • 4.2.1.2 Expanding Adoption of Minimally Invasive Surgery and Catheter-Based Procedures
    • 4.2.1.3 Accelerating Transition to Single-Use Medical Devices and Infection Control Imperatives
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Escalating Regulatory Compliance Burden Across Jurisdictions
    • 4.2.2.2 Health and Environmental Concerns Over PVC and Phthalate Plasticizers
    • 4.2.2.3 Raw Material Price Volatility and Petrochemical Supply Chain Exposure
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Advancements in biocompatible and smart materials
    • 4.2.3.2 Increasing government expenditure for upgrading and developing healthcare infrastructure
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Navigating an Increasingly Complex and Divergent Global Regulatory Environment
    • 4.2.4.2 Raw Material Supply Chain Fragility and Resin Price Volatility
    • 4.2.4.3 Chemical Safety Concerns and the DEHP/PVC Substitution Imperative
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN THE MEDICAL PLASTICS TUBING MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
• 4.6 PORTER'S FIVE FORCES ANALYSIS
  • 4.6.1 BARGAINING POWER OF SUPPLIERS
  • 4.6.2 BARGAINING POWER OF BUYERS
  • 4.6.3 THREAT OF SUBSTITUTES
  • 4.6.4 THREAT OF NEW ENTRANTS
  • 4.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 4.7 VALUE CHAIN ANALYSIS
• 4.8 ECOSYSTEM
• 4.9 PRICING ANALYSIS
  • 4.9.1 AVERAGE SELLING PRICE, BY REGION
  • 4.9.2 AVERAGE SELLING PRICE, BY KEY PLAYERS
  • 4.9.3 AVERAGE SELLING PRICE, BY MATERIAL
• 4.10 MACROECONOMIC INDICATORS
  • 4.10.1 GLOBAL GDP TRENDS
  • 4.10.2 HEALTHCARE INDUSTRY TRENDS
  • 4.10.3 PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY TRENDS
• 4.11 IMPACT OF 2025 US TARIFFS ON MEDICAL PLASTICS TUBING MARKET
  • 4.11.1 INTRODUCTION
  • 4.11.2 KEY TARIFF RATES
  • 4.11.3 PRICE IMPACT ANALYSIS
  • 4.11.4 IMPACT ON COUNTRIES/REGIONS
    • 4.11.4.1 US
    • 4.11.4.2 Europe
    • 4.11.4.3 Asia Pacific
  • 4.11.5 IMPACT ON END-USE INDUSTRIES
• 4.12 TRADE ANALYSIS
  • 4.12.1 IMPORT SCENARIO (HS CODE 3917)
  • 4.12.2 EXPORT SCENARIO (HS CODE 3917)
• 4.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 4.14 INVESTMENT AND FUNDING SCENARIO
• 4.15 CASE STUDY ANALYSIS
  • 4.15.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETER
  • 4.15.2 ZEUS ENABLES ADVANCED CATHETER CONSTRUCTION USING HEAT SHRINK TUBING
  • 4.15.3 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING
• 4.16 KEY CONFERENCES & EVENTS

5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 5.1 TECHNOLOGY ANALYSIS
  • 5.1.1 KEY TECHNOLOGY
    • 5.1.1.1 Advanced Multi-Layer Co-Extrusion Technology
    • 5.1.1.2 PFAS-Free and Next-Generation Fluoropolymer Alternatives
    • 5.1.1.3 Bioresorbable Polymer Tubing Technology
  • 5.1.2 COMPLEMENTARY TECHNOLOGY
    • 5.1.2.1 AI-Powered Inline Quality Inspection and Process Control Systems
    • 5.1.2.2 Digital Twin Technology for Manufacturing Process Optimization
• 5.2 TECHNOLOGY/PRODUCT ROADMAP
  • 5.2.1 SHORT TERM (2025-2027) | BIOCOMPATIBILITY ADVANCEMENT & PRECISION MANUFACTURING FOUNDATION
  • 5.2.2 MID-TERM (2027-2030) | SMART TUBING MANUFACTURING & SPECIALTY MATERIAL EXPANSION
  • 5.2.3 LONG TERM (2030-2030+) | AUTONOMOUS MANUFACTURING & NEXT-GENERATION MEDICAL PLASTICS TUBINGSYSTEMS
• 5.3 PATENT ANALYSIS
  • 5.3.1 LEGAL STATUS OF PATENTS
  • 5.3.2 JURISDICTION ANALYSIS
• 5.4 FUTURE APPLICATIONS
• 5.5 IMPACT OF AI/GEN AI ON MEDICAL PLASTICS TUBING MARKET
  • 5.5.1 TOP USE CASES AND MARKET POTENTIAL OF MEDICAL PLASTICS TUBING
  • 5.5.2 BEST PRACTICES IN MEDICAL PLASTICS TUBING PROCESSING
  • 5.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 5.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL PLASTICS TUBING MARKET

6 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

• 6.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.1.2 INDUSTRY STANDARDS
• 6.2 IMPACT OF REGULATORY POLICIES AND SUSTAINABILITY INITIATIVES
• 6.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 7.1 INTRODUCTION
• 7.2 DECISION-MAKING PROCESS
• 7.3 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 7.3.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
  • 7.3.2 BUYING CRITERIA
• 7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 7.5 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• 7.6 MARKET PROFITABILITY
  • 7.6.1 REVENUE POTENTIAL
  • 7.6.2 COST DYNAMICS
  • 7.6.3 MARGIN OPPORTUNITIES IN KEY END-USE INDUSTRIES

8 MEDICAL PLASTICS TUBING MARKET, BY MATERIAL

• 8.1 INTRODUCTION
• 8.2 POLYVINYL CHLORIDE (PVC)
  • 8.2.1 PERFORMS WELL IN HIGH-VOLUME EXTRUSION PROCESSES, MAKING IT SUITABLE FOR DISPOSABLE TUBING SETS AND COST-SENSITIVE HEALTHCARE APPLICATIONS
• 8.3 POLYETHYLENE (PE)
  • 8.3.1 KEY STRENGTHS OF PE IS ITS CHEMICAL INERTNESS AND RESISTANCE TO MANY AQUEOUS SOLUTIONS, BIOLOGICAL FLUIDS, AND MILD CHEMICALS
• 8.4 POLYPROPYLENE (PP)
  • 8.4.1 RESISTANCE TO MANY CHEMICALS AND ITS ABILITY TO WITHSTAND HIGHER TEMPERATURES COMPARED WITH SOME COMMODITY POLYMERS
• 8.5 POLYAMIDE (PA)
  • 8.5.1 POLYAMIDE OFFERS A STRONG BALANCE OF STIFFNESS AND FLEXIBILITY, DEPENDING ON THE GRADE SELECTED
• 8.6 POLYTETRAFLUOROETHYLENE (PTFE)
  • 8.6.1 PTFE REMAINS A CRITICAL MATERIAL IN HIGH-VALUE MEDICAL TUBING APPLICATIONS WHERE LUBRICITY, CHEMICAL INERTNESS, AND PERFORMANCE RELIABILITY ARE MORE IMPORTANT
• 8.7 POLYETHER ETHER KETONE (PEEK)
  • 8.7.1 PEEK IS PARTICULARLY VALUED WHEN THIN-WALL CONSTRUCTION, PRECISION TOLERANCES, AND HIGH MECHANICAL PERFORMANCE ARE REQUIRED
• 8.8 THERMOPLASTIC ELASTOMERS (TPE)
  • 8.8.1 OFFER GOOD ELASTIC RECOVERY, LOW-TEMPERATURE FLEXIBILITY, AND IMPROVED TACTILE FEEL COMPARED WITH MORE RIGID PLASTICS
• 8.9 OTHER MATERIALS

9 MEDICAL PLASTICS TUBING MARKET, BY STRUCTURE

• 9.1 INTRODUCTION
• 9.2 SINGLE-LUMEN
  • 9.2.1 EASIER TO DESIGN, EXTRUDE, INSPECT, ASSEMBLE, AND VALIDATE COMPARED WITH MORE COMPLEX TUBING STRUCTURES
• 9.3 MULTI-LUMEN
  • 9.3.1 HIGHLY VALUABLE IN ADVANCED MEDICAL DEVICES WHERE COMPACT DESIGN AND MULTIFUNCTIONALITY ARE ESSENTIAL
• 9.4 CO-EXTRUDED
  • 9.4.1 REQUIRES ADVANCED EXTRUSION CONTROL, STRONG MATERIAL COMPATIBILITY, AND CAREFUL VALIDATION OF LAYER ADHESION
• 9.5 TAPERED OR BUMP TUBING
  • 9.5.1 RELEVANT IN HIGH-PERFORMANCE CATHETER AND INTERVENTIONAL DEVICE APPLICATIONS
• 9.6 BRAIDED TUBING
  • 9.6.1 MORE COMPLEX TO MANUFACTURE THAN STANDARD EXTRUDED TUBING

10 MEDICAL PLASTICS TUBING MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 BULK DISPOSABLE TUBING
  • 10.2.1 MATERIAL CHOICE IN THIS APPLICATION IS STRONGLY INFLUENCED BY COST, REGULATORY ACCEPTANCE, FLEXIBILITY, CLARITY, AND COMPATIBILITY WITH HIGH-VOLUME MANUFACTURING
• 10.3 CATHETERS & CANNULAS
  • 10.3.1 STRONGLY DRIVEN BY THE SHIFT TOWARD MINIMALLY INVASIVE PROCEDURES, ADVANCED VASCULAR ACCESS, AND DEVICE MINIATURIZATION
• 10.4 DRUG DELIVERY SYSTEMS
  • 10.4.1 TUBING MUST NOT NEGATIVELY INTERACT WITH THE DRUG FORMULATION OR ALTER ITS STABILITY, POTENCY, OR DELIVERY PROFILE
• 10.5 OTHER APPLICATIONS

11 MEDICAL PLASTICS TUBING MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 FDA Regulatory Excellence, Robust Healthcare Spending, and Advanced Medical Device Manufacturing Sustain U.S. Leadership in the Medical Plastics Tubing Market
  • 11.2.2 CANADA
    • 11.2.2.1 Universal Healthcare Investments, Regulatory Modernization, and Expanding Homecare Services Accelerate Growth in the Canadian Medical Plastics Tubing Market
  • 11.2.3 MEXICO
    • 11.2.3.1 Nearshoring Investments, Export-Oriented Medical Device Manufacturing, and Regulatory Reforms Propel Mexico's Medical Plastics Tubing Market
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Advanced Medical Device Manufacturing, Healthcare Reforms, and an Aging Population Sustain Germany's Leadership in the European Medical Plastics Tubing Market
  • 11.3.2 FRANCE
    • 11.3.2.1 Biopharmaceutical Innovation, Government Healthcare Investments, and France 2030 Strategy Strengthen the Medical Plastics Tubing Market
  • 11.3.3 SPAIN
    • 11.3.3.1 Strong Economic Growth, Healthcare Digitalization, and Medical Device Investments Accelerate Spain's Medical Plastics Tubing Market
  • 11.3.4 UK
    • 11.3.4.1 NHS Investment, Regulatory Modernization, and Life Sciences Innovation Drive Growth in the United Kingdom Medical Plastics Tubing Market
  • 11.3.5 ITALY
    • 11.3.5.1 Mirandola Biomedical Cluster, Healthcare Modernization, and Medical Device Manufacturing Strength Drive Italy's Medical Plastics Tubing Market
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Manufacturing Scale, Regulatory Modernization, and Healthcare Investments Under the 14th Five-Year Plan Drive China's Medical Plastics Tubing Market
  • 11.4.2 JAPAN
    • 11.4.2.1 Aging Demographics, Rising Healthcare Expenditure, and Stringent Regulatory Standards Drive Japan's Medical Plastics Tubing Market
  • 11.4.3 INDIA
    • 11.4.3.1 Production-Linked Incentives, Healthcare Infrastructure Expansion, and Rising Domestic Manufacturing Propel India's Medical Plastics Tubing Market
  • 11.4.4 SOUTH KOREA
    • 11.4.4.1 Government MedTech Investments, Advanced Manufacturing, and Digital Healthcare Expansion Drive South Korea's Medical Plastics Tubing Market
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 MIDDLE EAST & AFRICA
  • 11.5.1 GCC COUNTRIES
    • 11.5.1.1 Healthcare Infrastructure Expansion, Rising Chronic Disease Burden, and Medical Technology Investments Drive the GCC Medical Plastics Tubing Market
    • 11.5.1.2 Saudi Arabia
      • 11.5.1.2.1 Vision 2030 Healthcare Transformation, Medical Infrastructure Investments, and Regulatory Modernization Drive Saudi Arabia's Medical Plastics Tubing Market
    • 11.5.1.3 UAE
      • 11.5.1.3.1 Healthcare Hub Development, Regulatory Transformation, and Medical Tourism Drive the UAE Medical Plastics Tubing Market
    • 11.5.1.4 Rest of GCC
  • 11.5.2 SOUTH AFRICA
    • 11.5.2.1 National Health Insurance Reform, Expanding Healthcare Access, and Rising Chronic Disease Burden Drive South Africa's Medical Plastics Tubing Market
  • 11.5.3 REST OF MIDDLE EAST & AFRICA
• 11.6 SOUTH AMERICA
  • 11.6.1 BRAZIL
    • 11.6.1.1 Universal Healthcare Expansion, Healthcare Infrastructure Investments, and Regulatory Modernization Drive Brazil's Medical Plastics Tubing Market
  • 11.6.2 ARGENTINA
    • 11.6.2.1 Macroeconomic Stabilization, Regulatory Modernization, and Rising Healthcare Demand Accelerate Argentina's Medical Plastics Tubing Market
  • 11.6.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS, 2021-2025
• 12.4 MARKET SHARE ANALYSIS, 2025
• 12.5 PRODUCT COMPARISON
• 12.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.6.1 STARS
  • 12.6.2 EMERGING LEADERS
  • 12.6.3 PERVASIVE PLAYERS
  • 12.6.4 PARTICIPANTS
  • 12.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 12.6.5.1 Company footprint
    • 12.6.5.2 Region footprint
    • 12.6.5.3 Material footprint
    • 12.6.5.4 Structure footprint
    • 12.6.5.5 Application footprint
• 12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 12.7.1 PROGRESSIVE COMPANIES
  • 12.7.2 RESPONSIVE COMPANIES
  • 12.7.3 DYNAMIC COMPANIES
  • 12.7.4 STARTING BLOCKS
  • 12.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 12.7.5.1 Detailed list of key startups/SMEs
    • 12.7.5.2 Competitive benchmarking of key startups/SMEs
• 12.8 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8.1 FINANCIAL METRICS
  • 12.8.2 COMPANY VALUATION
  • 12.8.3 ENTERPRISE VALUATION
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 SAINT-GOBAIN
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
      • 13.1.1.3.2 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 NORDSON CORPORATION
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 FREUDENBERG MEDICAL
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 TRELLEBORG AB
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 LUBRIZOL
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
      • 13.1.5.3.2 Deals
      • 13.1.5.3.3 Expansions
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 W. L. GORE & ASSOCIATES, INC.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
    • 13.1.6.4 MnM view
      • 13.1.6.4.1 Right to win
      • 13.1.6.4.2 Strategic choices
      • 13.1.6.4.3 Weaknesses and competitive threats
  • 13.1.7 BIOMERICS
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
    • 13.1.7.4 MnM view
  • 13.1.8 RAUMEDIC AG
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
      • 13.1.8.3.2 Deals
    • 13.1.8.4 MnM view
  • 13.1.9 ZEUS COMPANY LLC
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
    • 13.1.9.4 MnM view
  • 13.1.10 OPTINOVA
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 DAVIS-STANDARD CORPORATION
  • 13.2.2 PROTERIAL CABLE AMERICA, INC.
  • 13.2.3 ICO RALLY
  • 13.2.4 ICU MEDICAL, INC.
  • 13.2.5 KRATON CORPORATION
  • 13.2.6 MICROLUMEN INC.
  • 13.2.7 MDC INDUSTRIES
  • 13.2.8 NEWAGE INDUSTRIES
  • 13.2.9 PARKER HANNIFIN CORP.
  • 13.2.10 TEEL PLASTICS
  • 13.2.11 FBK MEDICAL TUBING
  • 13.2.12 SMOOTH-BOR PLASTICS
  • 13.2.13 JUNKOSHA INC.
  • 13.2.14 POLYZEN
  • 13.2.15 PEXCO

14 RESEARCH METHODOLOGY

• 14.1 RESEARCH DATA
  • 14.1.1 SECONDARY DATA
    • 14.1.1.1 Key data from secondary sources
  • 14.1.2 PRIMARY DATA
• 14.2 MARKET SIZE ESTIMATION
• 14.3 BASE NUMBER CALCULATION
  • 14.3.1 DEMAND-SIDE APPROACH
  • 14.3.2 SUPPLY-SIDE APPROACH
• 14.4 MARKET FORECAST APPROACH
• 14.5 DATA TRIANGULATION

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS